BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: She WH, Chan ACY, Cheung TT, Lo CM, Chok KSH. Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels. World J Hepatol 2018; 10(2): 308-318 [PMID: 29527266 DOI: 10.4254/wjh.v10.i2.308]
URL: https://www.wjgnet.com/1948-5182/full/v10/i2/308.htm
Number Citing Articles
1
Thorvardur R. Halfdanarson, Mohamed Bassam Sonbol, Jason S. Starr. Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease2023; : 358 doi: 10.1016/B978-0-323-68135-3.00051-9
2
Tsuyoshi Shimamura, Ryoichi Goto, Masaaki Watanabe, Norio Kawamura, Yasutsugu Takada. Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds?Cancers 2022; 14(2): 419 doi: 10.3390/cancers14020419
3
Shaakir Hasan, Stephen Abel, Tadahiro Uemura, Vivek Verma, Eugene J. Koay, Joseph Herman, Ngoc Thai, Alexander Kirichenko. Liver transplant mortality and morbidity following preoperative radiotherapy for hepatocellular carcinomaHPB 2020; 22(5): 770 doi: 10.1016/j.hpb.2019.10.006
4
A. V. Moiseenko, A. A. Polikarpov, D. A. Granov, P. G. Tarazov, C. V. Shapoval, A. R. Sheraliev, A. G. Karahanova. The possibilities of interventional radiology before and after orthotopic liver transplantationRussian Journal of Transplantology and Artificial Organs 2018; 20(3): 75 doi: 10.15825/1995-1191-2018-3-75-79
5
Bo Hu, Xiao-Bo Yang, Xin-Ting Sang. Liver graft rejection following immune checkpoint inhibitors treatment: a reviewMedical Oncology 2019; 36(11) doi: 10.1007/s12032-019-1316-7
6
Diamantis I. Tsilimigras, Fabio Bagante, Dimitrios Moris, Katiuscha Merath, Anghela Z. Paredes, Kota Sahara, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patientsSurgery 2019; 166(6): 967 doi: 10.1016/j.surg.2019.08.010
7
Alexander H. Shannon, Samantha M. Ruff, Austin D. Schenk, Kenneth Washburn, Timothy M. Pawlik. Updates and Expert Opinions on Liver Transplantation for Gastrointestinal MalignanciesMedicina 2023; 59(7): 1290 doi: 10.3390/medicina59071290
8
Sai Zhao, Zhi-Chao Liu, Yong-Xia Zhao, Tian-Le Zhang, Zi-Wei Zuo. A feasibility study of different GSI noise indexes and concentrations of contrast medium in hepatic CT angiography of overweight patients: image quality, radiation dose, and iodine intakeJapanese Journal of Radiology 2023; 41(6): 669 doi: 10.1007/s11604-022-01384-w
9
Bryan Cho Wing Li, Joanne Chiu, Kit Shing, Gerry Gin Wai Kwok, Vikki Tang, Roland Leung, Ka Wing Ma, Wong Hoi She, Josephine Tsang, Albert Chan, Tan To Cheung, Chung Mau Lo, Thomas Yau. The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver TransplantsAdvances in Therapy 2021; 38(7): 3900 doi: 10.1007/s12325-021-01800-z
10
Maria J Citores, Jose L Lucena, Sara de la Fuente, Valentin Cuervas-Mons. Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantationWorld Journal of Hepatology 2019; 11(1): 50-64 doi: 10.4254/wjh.v11.i1.50
11
Vasiliy I. Reshetnyak, Igor V. Maev, Tatiana M. Reshetnyak, Sergei V. Zhuravel, Vladimir M. Pisarev. Liver Disease and Hemostasis (Review) Part 2. Cholestatic Liver Disease and HemostasisGeneral Reanimatology 2019; 15(6): 80 doi: 10.15360/1813-9779-2019-6-80-93
12
Wong Hoi She, Miu Yee Chan, Ka Wing Ma, Simon H. Y. Tsang, Wing Chiu Dai, Albert C. Y. Chan, Chung Mau Lo, Tan To Cheung. Alpha-Fetoprotein in Predicting Survival of Patients with Ruptured Hepatocellular Carcinoma after ResectionJournal of Investigative Surgery 2022; 35(5): 1091 doi: 10.1080/08941939.2021.2012615
13
Beshoy Effat Elkomos, Mostafa Abdo, Remon Mamdouh, Amr Abdelaal. Can living donor liver transplantation provide similar outcomes to deceased-donor liver transplantation for hepatocellular carcinoma? A systematic review and meta-analysisHepatology International 2023; 17(1): 18 doi: 10.1007/s12072-022-10435-3
14
Yan-Ping Yu, Allan Tsung, Silvia Liu, Michael Nalesnick, David Geller, George Michalopoulos, Jian-Hua Luo. Detection of fusion transcripts in the serum samples of patients with hepatocellular carcinomaOncotarget 2019; 10(36): 3352 doi: 10.18632/oncotarget.26918
15
Chunling Wang, Xiaozhun Huang, Xiaofeng Lan, Dongmei Lan, Zhangkan Huang, Shu Ye, Yihong Ran, Xinyu Bi, Jianguo Zhou, Xu Che. Research progress of spontaneous ruptured hepatocellular carcinoma: Systematic review and meta-analysisFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.973857
16
Yajuan Sun, Can Yu, Xinxin Wang, Rui Yang, ZhiPeng Ding, Yang Zhou. Establishment and Validation of the LI-RADS Morphologic Type II Hepatocellular Carcinoma Early Recurrence Risk Scoring SystemJournal of Gastrointestinal Surgery 2023; 27(12): 2787 doi: 10.1007/s11605-023-05873-9
17
Arno Kornberg, Martina Schernhammer, Jennifer Kornberg, Helmut Friess, Katharina Thrum. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular CarcinomaDigestive Diseases and Sciences 2019; 64(1): 269 doi: 10.1007/s10620-018-5296-9
18
Andreas A. Schnitzbauer, Natalie Filmann, René Adam, Philippe Bachellier, Wolf O. Bechstein, Thomas Becker, Sherrie Bhoori, Itxarone Bilbao, Jens Brockmann, Patrizia Burra, Olivier Chazoullières, Umberto Cillo, Michele Colledan, Christoph Duvoux, Tom M. Ganten, Jean Gugenheim, Michael Heise, Bart van Hoek, Neville Jamieson, Koert P. de Jong, Christian G. Klein, Jürgen Klempnauer, Norman Kneteman, Jan Lerut, Heikki Mäkisalo, Vincenzo Mazzaferro, Darius F. Mirza, Silvio Nadalin, Peter Neuhaus, George-Philippe Pageaux, Antonio D. Pinna, Jaques Pirenne, Johann Pratschke, James Powel, Markus Rentsch, Magnus Rizell, Giorgio Rossi, Lionel Rostaing, André Roy, Tim Scholz, Utz Settmacher, Thomas Soliman, Simone Strasser, Gunnar Söderdahl, Roberto I. Troisi, Victor Sánchez Turrión, Hans J. Schlitt, Edward K. Geissler. mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAnnals of Surgery 2020; 272(5): 855 doi: 10.1097/SLA.0000000000004280
19
Paulo Henrique Lima, Boyan Fan, Joshua Bérubé, Milena Cerny, Damien Olivié, Jeanne-Marie Giard, Catherine Beauchemin, An Tang. Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular CarcinomaAmerican Journal of Roentgenology 2019; 213(1): 17 doi: 10.2214/AJR.18.20341